Hypoxia reverses a proteostasis-linked mitochondrial disease via HTRA2-CLPB axis
Reducing oxygen levels (hypoxia) can rescue a mitochondrial disease driven by proteostasis defects linked to the HTRA2–CLPB axis, extending oxygen-based therapy concepts beyond primary respiratory chain mutations.